Coronavirus Update: AbbVie Jumps Into Antiviral Research With Scripps Pact

AbbVie is taking the plunge into the highly competitive area of antiviral research through a new alliance, while Pfizer files for US approval of an additional mRNA booster shot and a vaccines group is unhappy about planned IP waivers. 

WTO HQ
proposed WTO TRIPS vaccine waivers seen as insufficient by vaccine alliance • Source: Alamy

More from COVID-19

More from Scrip